Norwegian biotech newcomer Nordic Nanovector (NANOV.OL), which seeks ways to treat blood-related cancers, says other companies are showing interest in buying the firm. “We talk a lot with companies, and as the data improves and the company develops, the more interest we have, that’s for sure,” chief executive officer Luigi Costa told Reuters. Read more.…